 |
|
|
| |
Lack of Drug Interactions Between Boosted and Unboosted
TAF-Based Antiretroviral Single-Tablet Regimens
(E/C/F/TAF, R/F/TAF) and the anti-HCV
Single-Tablet Regimen Ledipasvir/Sofosbuvir
|
| |
| |
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
Joseph M. Custodio, Eileen B. Doyle, Phillip S. Pang, Moupali Das,
Huyen Cao, Grace Ma, Anita Mathias, Julia Zack
Gilead Sciences, Inc., Foster, City, CA
|
| |
|
|
|
|
|
